MARISA NEZARIA: Open Payments
NPI 1437768728 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 13 payments from 8 companies in 2025. Trend: 2023 $39 · 2024 $62 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $133 |
| Lilly USA, LLC | 2 | $131 |
| AstraZeneca Pharmaceuticals LP | 4 | $123 |
| GlaxoSmithKline, LLC. | 1 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| PFIZER INC. | 1 | $27 |
| ABBVIE INC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: Yeztugo, KISUNLA, JARDIANCE, BREZTRI, AIRSUPRA, ELIQUIS, BOTOX, REXULTI.
Industry payments across MA — which companies pay providers there.
